Borax Triggers Ferroptosis by Modulating the TfR1/GPX4/ACSL4 Pathway in Prostate Cancer Cells with Differential Androgen Sensitivity

dc.contributor.authorBasaran, Ekrem
dc.contributor.authorHacioglu, Ceyhan
dc.contributor.authorBaba, Dursun
dc.contributor.authorTaskiran, Arda Taskin
dc.contributor.authorBalik, Ahmet Yildirim
dc.date.accessioned2026-07-01T11:40:07Z
dc.date.available2026-07-01T11:40:07Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description.abstractProstate carcinoma remains a predominant contributor to cancer-associated morbidity in males, with rising prevalence and therapeutic resistance highlighting unmet clinical needs. Ferroptosis-a non-apoptotic cell death mechanism mediated through iron-catalyzed phospholipid peroxidation-has emerged as a promising strategy to circumvent drug-resistant malignancies. We investigated the mechanistic interplay between transferrin receptor 1 (TfR1) and borax-mediated ferroptotic activation in androgen-responsive and androgen-independent prostate adenocarcinoma models. Cytotoxic effects of borax on LNCaP and DU-145 cells were assessed using CCK-8 and BrdU assays across 2.5 mu M to 320 mu M concentrations over 24-72 h. Expression and levels of TfR1, GPX4, ACSL4, GSH, MDA, total ROS, and intracellular Fe2(+) were evaluated through ELISA, Western blotting, and RT-PCR. Ferroptosis specificity was confirmed using ferrostatin-1 inhibition studies and exclusion of apoptosis/necroptosis/autophagy by pharmacological inhibitors. Nuclear alterations and superoxide anion production were examined using DAPI staining. IC50 values were 138 mu M (95% CI: 115-153 mu M) for LNCaP cells and 92.1 mu M (95% CI: 83.4-102 mu M) for DU-145 cells, with DU-145 demonstrating higher sensitivity. Borax exposure in DU-145 cells decreased GSH and GPX4 levels while increasing MDA, ROS, Fe2(+), ACSL4, and TfR1 expression. Ferrostatin-1 pretreatment effectively attenuated these effects, confirming ferroptosis-dependent mechanisms. Nuclear abnormalities and elevated superoxide production were observed. These findings demonstrate that borax induces cytotoxicity in prostate cancer cells through ferroptosis via TfR1/GPX4/ACSL4 cascade modulation, suggesting a potential role for TfR1 in governing ferroptotic vulnerability. While high concentrations limit immediate clinical application, these results establish mechanistic foundations for ferroptosis-targeted therapy development in prostate cancer.
dc.identifier.doi10.1007/s12011-025-04843-3
dc.identifier.endpage6558
dc.identifier.issn0163-4984
dc.identifier.issn1559-0720
dc.identifier.issue12
dc.identifier.orcid0000-0002-4779-6777
dc.identifier.orcid0000-0002-0993-6118
dc.identifier.orcid0000-0001-8319-512X
dc.identifier.pmid41053299
dc.identifier.scopus2-s2.0-105018007027
dc.identifier.scopusqualityQ1
dc.identifier.startpage6542
dc.identifier.urihttps://doi.org/10.1007/s12011-025-04843-3
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23649
dc.identifier.volume203
dc.identifier.wosWOS:001587264100001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringernature
dc.relation.ispartofBiological Trace Element Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20260623
dc.subjectBorax
dc.subjectTfr1
dc.subjectFerroptosis
dc.subjectProstate Cancer
dc.titleBorax Triggers Ferroptosis by Modulating the TfR1/GPX4/ACSL4 Pathway in Prostate Cancer Cells with Differential Androgen Sensitivity
dc.typeArticle

Dosyalar